Pathstone Holdings’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.31M Buy
82,327
+339
+0.4% +$13.2K 0.01% 719
2026
Q1
$2.9M Buy
81,988
+3,807
+5% +$118K 0.01% 832
2025
Q4
$2.19M Sell
78,181
-3,520
-4% -$105K 0.01% 974
2025
Q3
$2.45M Sell
81,701
-8,729
-10% -$246K 0.01% 907
2025
Q2
$2.59M Sell
90,430
-9,119
-9% -$271K 0.01% 856
2025
Q1
$3.29M Buy
99,549
+14,557
+17% +$475K 0.01% 721
2024
Q4
$2.44M Buy
84,992
+13,668
+19% +$393K 0.01% 866
2024
Q3
$2M Buy
71,324
+30,048
+73% +$801K 0.01% 967
2024
Q2
$995K Sell
41,276
-25,706
-38% -$631K ﹤0.01% 1330
2024
Q1
$1.81M Buy
66,982
+45,339
+209% +$1.29M 0.01% 953
2023
Q4
$600K Buy
+21,643
New +$562K ﹤0.01% 1385

Other funds holding ALKS

Pathstone Holdings's ALKS Position: Q2 2026 in Review

Pathstone Holdings increased its Alkermes (ALKS) stake by 0.41% in Q2 2026, buying an estimated $13.2K and bringing the position to 82,327 shares worth $4.31M. The position accounts for 0.01% of the portfolio, ranked #719.

Pathstone Holdings first reported a position in ALKS in Q4 2023 and has held it in 11 quarters since. 425 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Pathstone Holdings held 82,327 shares of Alkermes worth $4.31M as of Q2 2026.
  • Pathstone Holdings bought 339 Alkermes shares in Q2 2026, an estimated $13.2K.
  • Alkermes made up 0.01% of Pathstone Holdings's portfolio in Q2 2026, its #719 holding.
  • Pathstone Holdings first reported a position in Alkermes in Q4 2023 and has held it in 11 quarters since.
  • 425 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.